I look at this investment and Brilacidin in regard
Post# of 72447
(Total Views: 1059)
Posted On: 07/23/2020 11:17:47 AM
I look at this investment and Brilacidin in regards to CV19 as a major puzzle needing to connect many pieces of information to be able to see the clear picture.
I feel the President's comments yesterday regarding therapeutics and that a CURE may be on the doorstep is a major piece of the puzzle and relates directly to Brilacidin for the following reasons:
President is keeping B's name out of the headlines to make sure it is the "real deal" before bringing up the nation's (and the entire world's) hopes as to a solution to the CV19 problem.
The peer reviews are going to be published because big medicine wants a lot of professional input before unleashing a lot of money investigating B completely, not only for all coronaviruses but for the entire range of solutions it appears able to accomplish.
I think the RBL already has the C50 dosage established, and results known, in addition to the announced C90 dosage. As such, plans are well on the way for the B human trial. I think the SI has been shown to be quite high, in fact remarkably high, though not yet published.
I have no clue as to production of B-IV and how long it will take for enough to be available for LOTS of human trials. This could be the bottleneck at the current time, we just don't know. But if govt is throwing billions into vaccine doses for Pfizer product, they sure as hell have a hundred million to throw into production of B-IV NOW.
I no longer have any worries that Brilacidin's powerful data can be hidden as too many top names in many areas of medicine are now knowledgeable about its potential.
Lastly, I think the timing is going to be a bit more rapid in progressing over the next couple of months than has been let on to date.
My WAG.
I feel the President's comments yesterday regarding therapeutics and that a CURE may be on the doorstep is a major piece of the puzzle and relates directly to Brilacidin for the following reasons:
President is keeping B's name out of the headlines to make sure it is the "real deal" before bringing up the nation's (and the entire world's) hopes as to a solution to the CV19 problem.
The peer reviews are going to be published because big medicine wants a lot of professional input before unleashing a lot of money investigating B completely, not only for all coronaviruses but for the entire range of solutions it appears able to accomplish.
I think the RBL already has the C50 dosage established, and results known, in addition to the announced C90 dosage. As such, plans are well on the way for the B human trial. I think the SI has been shown to be quite high, in fact remarkably high, though not yet published.
I have no clue as to production of B-IV and how long it will take for enough to be available for LOTS of human trials. This could be the bottleneck at the current time, we just don't know. But if govt is throwing billions into vaccine doses for Pfizer product, they sure as hell have a hundred million to throw into production of B-IV NOW.
I no longer have any worries that Brilacidin's powerful data can be hidden as too many top names in many areas of medicine are now knowledgeable about its potential.
Lastly, I think the timing is going to be a bit more rapid in progressing over the next couple of months than has been let on to date.
My WAG.
(16)
(0)